Systemic Sclerosis (SSc) is a multisystem connective tissue disease of unknown etiology that is characterized by inflammation, vascular dysfunction and fibrosis of the skin and visceral organs. SSc is clinically diverse both in terms of the burden of skin and organ involvement and the rate of progression of the disease. Recent studies indicate that the endothelin system, especially ET-1 and the ETA and ETB receptors may play a key role in the pathogenesis of SSc. A new class of drugs, endothelin receptor antagonists has been introduced for treatment of patients with pulmonary arterial hypertension (PAH). Bosentan, a dual endothelin receptor antagonist as well as Sitaxsentan and Ambrisentan, selective blockers of the ETA receptor have proven effective in SSc-PAH. This effect may be mediated through both a vasodilatory and antifibrotic effect, thus making these agents attractive as potential disease modifying agents for SSc.
Keywords: Systemic sclerosis, scleroderma, endothelin receptor antagonists, bosentan, ambrisentan, sitaxsentan, fibrosis, heterogeneous autoimmune, blood vessels, visceral organs, endothelial injury, immune activation, extracellular matrix, skin, gastrointestinal tract, skeletal muscles, kidneys, heart, autoantibodies, anticentromere antibodies, antitopoisomerase I, endothelial dysfunction, infections, oxidative stress, proliferation, vasoconstrictors, vasodilators, vasoactive peptides, nitric oxide, vasodilatory, bronchoalveolar lavage (BAL), ischemic digital ulcers, vasculopathy, metalloproteinases, peribronchiolar, rodents mimics idiopathic, placebo, myocardial perfusion, Tissue-Doppler echocardiography, vasodilation, Raynaud's phenomenon, ulceration, vascular ectasia, scleroderma renal crisis, obliteration, retrospective study, dyspnea, pulmonary artery catheter, prostacyclin, hypertrophy, pulmonary hypertension, rheumatologic diseases
Dietary Small Molecules and Large-Scale Gene Expression Studies: An Experimental Approach for Understanding their Beneficial Effects on the Development of Malignant and Non-Malignant Proliferative Diseases
Current Medicinal Chemistry Persistent Pulmonary Hypertension of the Newborn: Therapeutical Approach
Mini-Reviews in Medicinal Chemistry Role of Carbon Monoxide in Kidney Function: Is a little Carbon Monoxide Good for the Kidney?
Current Pharmaceutical Biotechnology Dietary Factors and Hyperuricaemia
Current Pharmaceutical Design Blood Pressure Lowering and Outcomes in type 2 Diabetes: Implications of the Blood Pressure-Lowering Arm of the Advance Trial
Current Hypertension Reviews Cardiovascular Effects of Losartan and Its Relevant Clinical Application
Current Medicinal Chemistry Hypotensive Natural Products: Current Status
Mini-Reviews in Medicinal Chemistry Pensions and Low Sodium Salt: A Qualitative Evaluation of a New Strategy for Managing Hypertension in Rural South Africa
Current Aging Science The Etiology of Hypertension in the Metabolic Syndrome Part Three: The Regulation and Dysregulation of Blood Pressure
Current Vascular Pharmacology Vascular Pharmacotherapy and Dementia
Current Vascular Pharmacology Metabolic Syndrome and Asthma
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Under Re-organization) Metabolic Syndrome During Menopause
Current Vascular Pharmacology Effect of the Interaction Between Hypertension and Cerebral White Matter Changes on the Progression of Alzheimer Disease
Current Alzheimer Research Regulation of Vascular Endothelial Nitric Oxide Production by Fatty Acids
Current Organic Chemistry Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Blood Pressure Variability/Dipper/Non-dipper in Hypertension and Diabetes
Current Hypertension Reviews Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Effective Management of the Type 2 Diabetes Patient with Cardiovascular and Renal Disease: Secondary Prevention Strategies after a Myocardial Infarction
Current Diabetes Reviews Hyperuricemia: Is it a Risk Factor for Vascular Endothelial Dysfunction and Associated Cardiovascular Disorders?
Current Hypertension Reviews Cardioprotector Activity of an Esteroidal Saponin: A Scientific and Technological Prospection
Recent Patents on Biotechnology